SubHero Banner

COVID-19 vaccines – VRBPAC makes recommendations for new monovalent vaccine composition

June 15, 2023 - The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted for the 2023-2024 formula of COVID-19 vaccines in the U.S to include a periodic update of the current vaccine composition to a monovalent XBB-lineage.

Download PDF